Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead's third-quarter earnings beat by a wide margin, and biotech raises guidance
04:36pm, Wednesday, 06'th Nov 2024
Gilead Sciences Inc.'s stock rose 2% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and COVID-19
Gilead 3rd-quarter results beat Wall Street estimates, raises outlook
04:20pm, Wednesday, 06'th Nov 2024
Gilead Sciences reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%, leading the drugmaker to raise its outlook for full-year earnings.
Gilead Sciences Announces Third Quarter 2024 Financial Results
04:02pm, Wednesday, 06'th Nov 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2024 results of operations. “Gilead's third quarter results are the strongest
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
04:00pm, Tuesday, 05'th Nov 2024
Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their earnings releases this week.
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), will share 18 presentations, including six oral presentations, demonstrating the strength of its CAR T-cell therapy portfo
Ahead of Gilead (GILD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:20am, Friday, 01'st Nov 2024
Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Thursday, 31'st Oct 2024
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to Decline
11:06am, Wednesday, 30'th Oct 2024
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
07:06pm, Tuesday, 29'th Oct 2024
Gilead Sciences (GILD) reachead $88.08 at the closing of the latest trading day, reflecting a -0.77% change compared to its last close.
3 Absurdly Cheap Stocks That Pay High Dividends
08:15am, Thursday, 24'th Oct 2024
These stocks are trading at less than 15 times their expected future profits.
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today
07:05pm, Wednesday, 23'rd Oct 2024
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $87.23, denoting a -1.05% change from the preceding trading day.
Calls of the Day: Gilead, Berkshire Hathaway and SLB
01:34pm, Monday, 21'st Oct 2024
The Investment Committee debate the latest Calls Of The Day
FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results from
Gilead voluntarily withdraws urothelial cancer drug in US
08:50am, Friday, 18'th Oct 2024
Gilead Sciences said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients with a type of urothelial cancer after consultation with the regulator.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 17'th Oct 2024
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
